ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

What’s the deal with CRISPR? – McGill Tribune

Continue reading

2017-03-28 Michael Zand NEWS

EMA Paves the Way for a New Blood Cancer Immunotherapy for Children – Labiotech.eu (blog)

Labiotech.eu (blog)EMA Paves the Way for a New Blood Cancer Immunotherapy for ChildrenLabiotech.eu (blog)ATIR101 is a T-cell immunotherapy that eliminates alloreactive cells from the donor to minimize the risk of graft-versus-host disease (GVHD) in … Continue reading

2017-03-28 Michael Zand NEWS

Global Stem Cell Umbilical Cord Blood Market 2017 : Cryosite, Stemlife, Smart Cells, LifeCell, Cryolife – Medgadget (blog)


McGill Tribune

What’s the deal with CRISPR?
McGill Tribune
CRISPR offers the potential to cure presently untreatable cancers and diseases. Moreover, it could revive an extinct organism, such as the mammoth, using tiny bits of genomic information that scientists have collected through their serendipitous …
European Patent Office to Grant Broad Claims on Patent Covering CRISPR-Cas9 Gene Editing TechnologyBusiness Wire (press release)

all 3 news articles »

Continue reading

2017-03-28 Michael Zand NEWS

European Patent Office to Grant Broad Claims on Patent Covering CRISPR-Cas9 Gene Editing Technology – Yahoo Finance

European Patent Office to Grant Broad Claims on Patent Covering CRISPR-Cas9 Gene Editing TechnologyYahoo FinanceThe claims intended for grant by the EPO are directed to the widely-used single-guide CRISPR-Cas9 gene editing system and cover uses in both… Continue reading

2017-03-28 Michael Zand NEWS

New Tools to Study the Origin of Embryonic Stem Cells – Technology Networks


The Independent

Global Stem Cell Umbilical Cord Blood Market 2017 : Cryosite, Stemlife, Smart Cells, LifeCell, Cryolife
Medgadget (blog)
The Global Stem Cell Umbilical Cord Blood Market Key Vendors are Stemcyte Inc, Cell Care, Smart Cells, LifeCell, Cryolife, Healthbanks Biotech, StemOne Biologicals, Cryosite, Stemlife, cordlife, Cells for Life . The report, named “Global Stem Cell …
The life cordDaily Pioneer
How umbilical cords are saving the lives of cancer patientsThe Independent

all 5 news articles »

Continue reading

2017-03-28 Michael Zand NEWS

Why did Biotech Beat Pharma to Bring the First Gene Therapy to Market? – Labiotech.eu (blog)

New Tools to Study the Origin of Embryonic Stem Cells
Technology Networks
The blastocyst then attaches itself to the wall of the uterus (implantation), and for a limited period from fertilisation to a few days after implantation the embryo contains pluripotent stem cells. These cells can develop into all the body’s cell …

and more »

Continue reading

2017-03-28 Michael Zand NEWS

Why did Biotech Beat Pharma to Bring the First Gene Therapy to … – Labiotech.eu (blog)

Why did Biotech Beat Pharma to Bring the First Gene Therapy to Market?
Labiotech.eu (blog)
Pharma would seemingly best biotech in any competition. A few CEO’s explain why it left the honor of “The World’s First Gene Therapy” to biotech. On July 20, 2012, the world’s first gene therapy, Glybera, received marketing authorization from the EMA.

Continue reading

2017-03-28 Michael Zand NEWS

From synthetic biology to global health challenges – University of Bristol

Why did Biotech Beat Pharma to Bring the First Gene Therapy to …
Labiotech.eu (blog)
Pharma would seemingly best biotech in any competition. A few CEO’s explain why it left the honor of “The World’s First Gene Therapy” to biotech.

and more »

Continue reading

2017-03-28 Michael Zand NEWS
  • 1
  • …
  • 1,922
  • 1,923
  • 1,924
  • 1,925
  • 1,926
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

From synthetic biology to global health challenges
University of Bristol
The new Bristol Biodesign Institute (BBI) builds on a £70 million investment in synthetic biology at the University, which includes a synthetic biology research centre and a centre for doctoral training. The BBI will be the focal point for …